Bullfrog AI Holdings Inc. (NASDAQ:BFRG – Get Free Report) CFO Joshua Blacher bought 50,000 shares of the firm’s stock in a transaction on Tuesday, September 22nd. The stock was purchased at an average price of $0.53 per share, with a total value of $26,500.00. Following the transaction, the chief financial officer owned 65,000 shares in the company, valued at $34,450. The trade was a 333.33% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link.
Bullfrog AI Trading Up 21.7%
BFRG opened at $0.60 on Wednesday. The business’s 50 day moving average is $0.56 and its 200-day moving average is $0.68. The stock has a market cap of $11.12 million, a PE ratio of -1.30 and a beta of -2.71. Bullfrog AI Holdings Inc. has a twelve month low of $0.43 and a twelve month high of $2.04.
Bullfrog AI (NASDAQ:BFRG – Get Free Report) last issued its quarterly earnings data on Friday, August 14th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.04. The business had revenue of $0.22 million during the quarter, compared to the consensus estimate of $0.21 million. As a group, analysts forecast that Bullfrog AI Holdings Inc. will post -0.37 EPS for the current year.
Institutional Trading of Bullfrog AI
Analyst Upgrades and Downgrades
BFRG has been the subject of several recent analyst reports. Wall Street Zen raised Bullfrog AI from a “sell” rating to a “hold” rating in a research note on Saturday, July 4th. Weiss Ratings downgraded shares of Bullfrog AI from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, September 16th. Finally, Zacks Research raised shares of Bullfrog AI to a “hold” rating in a report on Friday, June 26th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Reduce”.
Read Our Latest Report on Bullfrog AI
About Bullfrog AI
BullFrog AI Holdings, Inc is a biotechnology and technology company that applies artificial intelligence and machine learning to drug development and precision medicine. The company focuses on helping pharmaceutical, biotechnology and healthcare organizations analyze complex biomedical data and identify insights that may support research and clinical decision-making.
Its primary platform, bfLEAP, is designed to process and analyze large, multidimensional datasets, including clinical, genomic and other healthcare-related information.
Featured Articles
- Five stocks we like better than Bullfrog AI
- Meta’s Muse Highlights Arm’s Growing Role in AI Infrastructure
- Oura’s $15.6 Billion IPO Is Betting Investors See More Than a Smart Ring
- AMD Chips Away at NVIDIA’s AI Throne
- Is the Fed Playing Chess With Rates—Or Just Behind the Curve Again?
Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.
